cato.com
Cato Strategic Locations | Cato Research Communications Registry | Cato Research - Contract Research Organization | Research Triangle Park, Durham, North Carolina
http://www.cato.com/cato-strategic-locations.shtml
Chemistry, Manufacturing,. Data Management and Biostatistics. Preclinical / Nonclinical Services. Quality Clinical Trial Oversight. Cato Research has in-house capabilities to assist sponsors with all aspects of the drug development process. Obstetrics / Gynecology / Women’s Health. Regenerative Medicine / Cell Therapies / Stem Cells. Respiratory Disorder / Pulmonology. As an expanding contract research organization, Cato Research is constantly on the move, growing and keeping up-to-date with the latest a...
ask-cato.com
New FDA Guidances for February 2015 - Ask Cato ResearchAsk Cato Research
http://www.ask-cato.com/2015/03/new-fda-guidances-february-2015
Authoring for eCTD – Know the Requirements and Think Like a Reviewer. Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs) →. New FDA Guidances for February 2015. By Sheila R. Plant, Ph.D., R.A.C., Regulatory Scientist at Cato Research. Classifying Resubmissions of Original NDAs, BLAs, and Efficacy Supplements in Response to Action Letters. 8211; MAPP (CDER). Tertiary Review of Genetic Toxicology Studies Resulting in a Recommendation for a Clinical Hold or Conduct of Additional Studies.
ask-cato.com
New FDA Guidances for April 2015 - Ask Cato ResearchAsk Cato Research
http://www.ask-cato.com/2015/05/new-fda-guidances-for-april-2015
New FDA Guidances for March 2015. New FDA Guidances for May 2015 →. New FDA Guidances for April 2015. By Sheila R. Plant, Ph.D., R.A.C., Regulatory Scientist at Cato Research. FDA draft and final guidances, released from CDER, CBER, and CDRH in April 2015, are posted. In addition, upcoming advisory committee meetings to be held in the next couple months are listed below with links to more information. 8211; Final Guidance. 8211; Final Guidance. 8211; Final Guidance. 8211; Draft Guidance. Balancing Premar...
hemodynamictx.com
About Hemodynamic Therapeutics | Hemodynamic Theraputics
http://www.hemodynamictx.com/about_Hemodynamic-Therapeutics.html
Was formed in 2004 as a majority-owned portfolio company of Cato BioVentures. Through its strategic development relationship with Cato BioVentures and its contract research and development affiliate, Cato Research Ltd. Is executing its phase 2 development program for. 101, a novel small molecule combination therapy for obesity-related hypertension (ORH), one of the world’s fastest growing cardiovascular disease markets.
canceradvancesinc.com
Cancer Advances Inc. Product | Polyclonal Antibody Stimulator (PAS) | RTP, Durham, North Carolina
http://canceradvancesinc.com/cancer-advances-product.html
Polyclonal Antibody Stimulator (PAS). Polyclonal Antibody Stimulator (PAS) is a fusion peptide being developed for the treatment. Of gastrointestinal cancers, metastatic gastrinoma, and colorectal adenoma. Cancer Advances was created as a wholly owned subsidiary of Cato BioVentures.
canceradvancesinc.com
About | Executive Team | Cancer Advances Inc. | RTP, Durham, North Carolina
http://canceradvancesinc.com/about-cancer-advances.html
Polyclonal Antibody Stimulator (PAS). Cancer Advances is a company led by an experienced team with more than 100 years. Of combined industry experience. Allen Cato, Chief Executive Officer and Chief Medical Officer. Allen Cato, M.D., Ph.D. cofounded Cato Research. Lynda Sutton, President. Lynda Sutton, B.S. currently serves as the President and Chief Regulatory Officer for Cato Research. Allen (Jo) Cato, Ph.D., Senior Vice President of Drug Development.
canceradvancesinc.com
Cancer Advances Inc. Product | Polyclonal Antibody Stimulator (PAS) | RTP, Durham, North Carolina
http://canceradvancesinc.com/product.html
Polyclonal Antibody Stimulator (PAS). Polyclonal Antibody Stimulator (PAS) is a fusion peptide being developed for the treatment. Of gastrointestinal cancers, metastatic gastrinoma, and colorectal adenoma. Cancer Advances was created as a wholly owned subsidiary of Cato BioVentures.
cato.com
Services | Clinical Trials, Regulatory Affairs, Preclinical, Project Management | Drug Development
http://www.cato.com/services.shtml
Chemistry, Manufacturing,. Data Management and Biostatistics. Preclinical / Nonclinical Services. Quality Clinical Trial Oversight. Cato Research has in-house capabilities to assist sponsors with all aspects of the drug development process. Obstetrics / Gynecology / Women’s Health. Regenerative Medicine / Cell Therapies / Stem Cells. Respiratory Disorder / Pulmonology. As an expanding contract research organization, Cato Research is constantly on the move, growing and keeping up-to-date with the latest a...
SOCIAL ENGAGEMENT